Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes Darren K
The report is the first to examine how injectable semaglutide may improve reproductive outcomes in women with PMOS while also addressing obesity and metabolic dysfunction
Gl bir antioksidan olan glutatyon, son zamanlarda salk ve gzellik alanlarnda olduka popler bir terim haline geldi
As noted above, anti-diabetic actions of myricetin are summarized as 1) inhibitors of -glucosidase and -amylase for prevention of carbohydrate digestion, 2) inhibitors of GLUT2 for suppression of glucose absorption through a specific transporter, 3) elevation of GLUT4 expression for enhancement of insulin-dependent glucose uptake into the target organs, 4) an agonist for GLP-1R to enhance insulin secretion, suppression of glucagon secretion, and protection of pancreatic -cells, 5) DPP-4 inhibitors for prevention of GLP-1 degradation, and 6) prevention of hIAPP aggregation and NLRP3 activation for protection of pancreatic -cell, 7) protection of endothelial cells from HG-induced apoptosis, 8) protection against diabetic osteoporosis, 10) prevention of DNP through suppression of oxidative stress and 11) improvement of the intestinal flora